Characterization of a variety of neutralizing anti-heparin-binding epidermal growth factor-like growth factor monoclonal antibodies by different immunization methods

mAbs

Volumn 4, Issue 6, 2012, Pages 732-739

  Tsuji, Isamu ^a   Sato, Shuji ^a   Otake, Kentaro ^a   Watanabe, Takahiro ^a   Kamada, Hiroko ^a   Kurokawa, Tomofumi ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

Antibody generation; Epidermal growth factor receptor; Heparin binding epidermal growth factor like growth factor; Immunization; Neutralizing antibody

Indexed keywords

ANTIGEN; BOVINE SERUM ALBUMIN; EPITOPE; HEPARIN BINDING EPIDERMAL GROWTH FACTOR MONOCLONAL ANTIBODY; KEYHOLE LIMPET HEMOCYANIN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BIOLOGICAL ACTIVITY; CANCER IMMUNIZATION; COLONY FORMATION; CONTROLLED STUDY; DRUG BINDING; ELECTROFUSION (CELL); FLUOROMETRY; HYBRIDOMA; MOUSE; NONHUMAN;

ANTIBODY GENERATION; EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARIN-BINDING EPIDERMAL GROWTH FACTOR-LIKE GROWTH FACTOR; IMMUNIZATION; NEUTRALIZING ANTIBODY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; DRUG ADMINISTRATION ROUTES; EPIDERMAL GROWTH FACTOR; HEPARIN; HUMANS; HYBRIDOMAS; IMMUNIZATION; MICE; MICE, INBRED STRAINS; NEOPLASMS;

EID: 84869840543     PISSN: 19420862     EISSN: 19420870     Source Type: Journal    
DOI: 10.4161/mabs.21929     Document Type: Article

References (29)

1. Higashiyama S, Lau K, Besner GE, Abraham JA, Klagsbrun M. Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. J Biol Chem 1992; 267:6205-12; PMID:1556128
2. Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 1991; 251:936-9; http://dx.doi.org/10.1126/science.1840698; PMID:1840698
3. Kobrin MS, Funatomi H, Friess H, Buchler MW, Stathis P, Korc M. Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer. Biochem Biophys Res Commun 1994; 202:1705-9; http://dx.doi.org/10.1006/ bbrc.1994.2131; PMID:8060360
4. Mishima K, Higashiyama S, Asai A, Yamaoka K, Nagashima Y, Taniguchi N, et al. Heparin-binding epidermal growth factor-like growth factor stimulates mitogenic signaling and is highly expressed in human malignant gliomas. Acta Neuropathol 1998; 96:322-8; http://dx.doi.org/10.1007/s004010050901; PMID:9796995
5. Miyamoto S, Hirata M, Yamazaki A, Kageyama T, Hasuwa H, Mizushima H, et al. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy. Cancer Res 2004; 64:5720-7; http://dx.doi.org/10.1158/0008-5472. CAN-04-0811; PMID:15313912
6. Naef M, Yokoyama M, Friess H, Büchler MW, Korc M. Co-expression of heparin-binding EGF-like growth factor and related peptides in human gastric carcinoma. Int J Cancer 1996; 66:315-21; http://dx.doi.org/10.1002/(SICI)1097- 0215(19960503)66:3〈315::AIDIJC8〉3.0.CO;2-1; PMID:8621250
7. Thøgersen VB, Sørensen BS, Poulsen SS, Orntoft TF, Wolf H, Nexo E. A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients. Cancer Res 2001; 61:6227-33; PMID:11507076
8. Hoffmann AC, Danenberg KD, Taubert H, Danenberg PV, Wuerl P. A three-gene signature for outcome in soft tissue sarcoma. Clin Cancer Res 2009; 15:5191-8; http://dx.doi.org/10.1158/1078-0432.CCR-08-2534; PMID:19671876
9. Tanaka Y, Miyamoto S, Suzuki SO, Oki E, Yagi H, Sonoda K, et al. Clinical significance of heparinbinding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer. Clin Cancer Res 2005; 11:4783-92; http://dx.doi.org/10.1158/1078-0432.CCR-04-1426; PMID:16000575
10. Hamaoka M, Chinen I, Murata T, Takashima S, Iwamoto R, Mekada E. Anti-human HB-EGF monoclonal antibodies inhibiting ectodomain shedding of HB-EGF and diphtheria toxin binding. J Biochem 2010; 148:55-69; http://dx.doi.org/10. 1093/jb/mvq033; PMID:20332144
11. Khong TF, Fraser S, Katerelos M, Paizis K, Hill PA, Power DA. Inhibition of heparin-binding epidermal growth factor-like growth factor increases albuminuria in puromycin aminonucleoside nephrosis. Kidney Int 2000; 58:1098-107; http://dx.doi.org/10.1046/j.1523-1755.2000.00267.x; PMID:10972674
12. Miyamoto S, Iwamoto R, Furuya A, Takahashi K, Sasaki Y, Ando H, et al. A novel anti-human HB-EGF monoclonal antibody with multiple antitumor mechanisms against ovarian cancer cells. Clin Cancer Res 2011; 17:6733-41; http://dx.doi.org/10.1158/1078-0432.CCR-11-1029; PMID:21918176
13. Stollar BD, Fuchs S, Mozes E. Immune response of mice to nucleic acids: strain-dependent differences in magnitude and class of antibody production. J Immunol 1973; 111:121-9; PMID:4576583
14. Hoffenbach A, Lagrange PH, Bach MA. Strain variation of lymphokine production and specific antibody secretion in mice infected with Mycobacterium lepraemurium. Cell Immunol 1985; 91:1-11; http://dx.doi.org/10.1016/0008- 8749(85)90026-7; PMID:3882240
15. Kasai K, Teuscher C, Smith S, Matzner P, Tung KS. Strain variations in anti-sperm antibody responses and anti-fertility effects in inbred mice. Biol Reprod 1987; 36:1085-94; http://dx.doi.org/10.1095/biolreprod36.5.1085; PMID:3620556
16. Baraldo K, Mori E, Bartoloni A, Petracca R, Giannozzi A, Norelli F, et al. N19 polyepitope as a carrier for enhanced immunogenicity and protective efficacy of meningococcal conjugate vaccines. Infect Immun 2004; 72:4884-7; http://dx.doi.org/10.1128/IAI.72.8.4884-4887.2004; PMID:15271954
17. Defendini ML, Pierres M, Regnier-Vigouroux A, Rochat H, Granier C. Epitope mapping of apamin by means of monoclonal antibodies raised against free or carrier-coupled peptide. Mol Immunol 1990; 27:551-8; http://dx.doi.org/10. 1016/0161-5890(90)90074-A; PMID:1696354
18. Karle S, Nishiyama Y, Taguchi H, Zhou YX, Luo J, Planque S, et al. Carrier-dependent specificity of antibodies to a conserved peptide determinant of gp120. Vaccine 2003; 21:1213-8; http://dx.doi.org/10.1016/S0264-410X(02) 00504-2; PMID:12559800
19. Amagai M. Autoimmune and infectious skin diseases that target desmogleins. Proc Jpn Acad Ser B Phys Biol Sci 2010; 86:524-37; http://dx.doi.org/10.2183/pjab.86.524; PMID:20467217
20. Ladner RC. Mapping the epitopes of antibodies. Biotechnol Genet Eng Rev 2007; 24:1-30; PMID:18059626
21. Swartzman EE, Miraglia SJ, Mellentin-Michelotti J, Evangelista L, Yuan PM. A homogeneous and multiplexed immunoassay for high-throughput screening using fluorometric microvolume assay technology. Anal Biochem 1999; 271:143-51; http://dx.doi.org/10.1006/abio.1999.4128; PMID:10419629
22. Defize LH, Boonstra J, Meisenhelder J, Kruijer W, Tertoolen LG, Tilly BC, et al. Signal transduction by epidermal growth factor occurs through the subclass of high affinity receptors. J Cell Biol 1989; 109:2495-507; http://dx.doi.org/10.1083/jcb.109.5.2495; PMID:2553748
23. Lax I, Bellot F, Howk R, Ullrich A, Givol D, Schlessinger J. Functional analysis of the ligand binding site of EGF-receptor utilizing chimeric chicken/human receptor molecules. EMBO J 1989; 8:421-7; PMID:2785915
24. Lax I, Fischer R, Ng C, Segre J, Ullrich A, Givol D, et al. Noncontiguous regions in the extracellular domain of EGF receptor define ligand-binding specificity. Cell Regul 1991; 2:337-45; PMID:1716463
25. Ogiso H, Ishitani R, Nureki O, Fukai S, Yamanaka M, Kim JH, et al. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 2002; 110:775-87; http://dx.doi.org/10.1016/S0092- 8674(02)00963-7; PMID:12297050
26. Jin P, Zhang J, Beryt M, Turin L, Brdlik C, Feng Y, et al. Rational optimization of a bispecific ligand trap targeting EGF receptor family ligands. Mol Med 2009; 15:11-20; http://dx.doi.org/10.2119/molmed.2008.00103; PMID:19048033
27. Giorgio C, Hassan Mohamed I, Flammini L, Barocelli E, Incerti M, Lodola A, et al. Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation. PLoS One 2011; 6:e18128; http://dx.doi.org/10.1371/journal.pone. 0018128; PMID:21479221
28. Beerli RR, Hynes NE. Epidermal growth factorrelated peptides activate distinct subsets of ErbB receptors and differ in their biological activities. J Biol Chem 1996; 271:6071-6; http://dx.doi.org/10.1074/jbc.271.11.6071; PMID:8626392
29. Engvall E, Perlmann P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry 1971; 8:871-4; http://dx.doi.org/10.1016/0019-2791(71)90454-X; PMID:5135623